Navigation Links
Reportlinker Adds Top Ten World's Leading Pharmaceutical Companies
Date:11/16/2010

NEW YORK, Nov. 16, 2010 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Top Ten World's Leading Pharmaceutical Companies

http://www.reportlinker.com/p0329551/Top-Ten-World's-Leading-Pharmaceutical-Companies.html

A thought-provoking report on performance, capabilities, goals and strategies of the major competitors in the worldwide pharmaceutical market. The report is designed to provide the pharmaceutical industry executives with strategically significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report's major objectives include:

  • To establish a comprehensive, factual, annually-updated and cost-effective information base on performance, capabilities, goals and strategies of the world's leading pharmaceutical companies.
  • To help current suppliers realistically assess their financial, marketing and technological capabilities vis-a-vis leading competitors.
  • To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates.
  • To complement organizations' internal competitor information gathering efforts by providing strategic analysis, data interpretation and insight.
  • To identify the least competitive market niches with significant growth potential.

  • Contains 1,200 pages and 100 tables

    SECTION I: EXECUTIVE SUMMARY

    • A 5-10 page synopsis of key sections.

    SECTION II: BUSINESS ORGANIZATION

    • History of the company's pharmaceutical business evolution,

    which is important to understanding the corporate culture,

    management mentality, and strategies.

    • Most recent M&A activity and significant organizational changes.

    • Current organizational structure.

    SECTION III: SENIOR MANAGEMENT

    • Names, titles, and background of senior managers.

    SECTION IV: FACILITIES AND EMPLOYEES

    • Major administrative, manufacturing, and R&D facilities

    in the U.S. and abroad.

    • Manufacturing practices.

    • New plants under construction.

    • U.S. and international work force size and distribution.

    SECTION V: TECHNOLOGICAL KNOW-HOW

    • Internally developed and acquired technologies,

    processes, and related capabilities.

    • Know-how in biotechnology and other pertinent fields.

    • Proprietary technologies and patent litigations.

    SECTION VI: PRODUCT PORTFOLIO ANALYSIS

    • Extensive review of major ethical, OTC, and generic drugs.

    • Most recent new drug introductions and indications.

    SECTION VII: MARKETING TACTICS

    • Sales force in the U.S., Europe, and other regions.

    • Distribution strategies.

    • Major promotional tactics.

    SECTION VIII: FINANCIAL ANALYSIS

    • The U.S. and international sales and operating profit estimates by

    division, geographic region, therapeutic category, and individual drug.

    • The five-year sales and operating profit performance.

    • AstraZeneca

    • Eli Lilly

    • GlaxoSmithKline

    • Johnson & Johnson

    • Merck

    • Novartis

    • Pfizer

    • Roche

    • Sanofi-Aventis

    • Wyeth

    SECTION IX: R&D EXPENDITURES AND

    MAJOR PROGRAMS

    • The R&D budget.

    • Research facilities and staff.

    • New technologies, drugs, and indications in development,

    including their phase and anticipated introduction dates.

    • Worldwide sales force size.

    SECTION X: COLLABORATIVE ARRANGEMENTS

    • Major joint venture, distribution, OEM, and licensing partners, both

    industrial and academic.

    • Terms of collaborative agreements and specific products involved.

    SECTION XI: STRATEGIC DIRECTION

    • Major strengths and weaknesses.

    • Business, new product development, and marketing objectives

    and strategies.

    • Anticipated acquisitions, joint ventures, and divestitures.

    LIST OF TABLESTable MO-1: World Pharmaceutical Market

    by Major Product Segment

    Table MO-2: World Ethical Pharmaceutical Market

    by Geographic Region/Country

    Table MO-3: World Ethical Pharmaceutical Market

    by Major Drug Category

    Table AZ-1: AstraZeneca Sales and Operating Profit Growth

    Table AZ-2: AstraZeneca Sales by Therapeutic Category/Business

    Table AZ-3: AstraZeneca Sales Growth by Therapeutic

    Category/Business

    Table AZ-4: AstraZeneca Sales by Major Drug/Business

    Table AZ-5: AstraZeneca Sales Growth by Major Drug/Business

    Table AZ-6: AstraZeneca Sales by Major Drug/Business and

    Geographic Region

    Table AZ-7: AstraZeneca Sales by Geographic Region and

    Country

    Table AZ-8: AstraZeneca Sales Growth by Geographic Region and

    Country

    Table BM-1: Bristol-Myers Squibb Sales and Operating Profit

    Growth

    Table BM-2: Bristol-Myers Squibb Sales by Major Division

    Table BM-3: Bristol-Myers Squibb Sales by Major Division and

    Geographic Region

    Table BM-4: Bristol-Myers Squibb Sales Growth by Major Division

    Table BM-5: Bristol-Myers Squibb Sales by Therapeutic Category

    Table BM-6: Bristol-Myers Squibb Sales by Therapeutic Category

    and Geographic Region

    Table BM-7: Bristol-Myers Squibb Sales Growth by Therapeutic

    Category

    Table BM-8: Bristol-Myers Squibb Sales by Major Drug

    Table BM-9: Bristol-Myers Squibb Sales Growth by Major Drug

    Table BM-10: Bristol-Myers Squibb Sales by Product Line

    Table BM-11: Bristol-Myers Squibb Sales Growth by Product Line

    Table BM-12: Bristol-Myers Squibb Sales by Geographic Region

    Table BM-13: Bristol-Myers Squibb Sales Growth by Geographic

    Region

    Table BM-14: Bristol-Myers Squibb Other Health Care Sales by

    Product

    Table GL-1: GlaxoSmithKline Sales by Business Segment

    Table GL-2: GlaxoSmithKline Sales Growth by Business Segment

    Table GL-3: GlaxoSmithKline Operating Profit And Margins by

    Business Segment

    Table GL-4: GlaxoSmithKline Operating Profit by Business

    Segment

    Table GL-5: GlaxoSmithKline Sales and Operating Profit Growth

    Table GL-6: GlaxoSmithKline Sales by Major Drug

    Table GL-7: GlaxoSmithKline Sales by Drug and Geographic Region

    Table GL-8: GlaxoSmithKline Sales by Therapeutic Category

    Table GL-9: GlaxoSmithKline Sales Growth by Therapeutic

    Category

    Table GL-10: GlaxoSmithKline Sales by Geographic Region and Country

    Table GL-11: GlaxoSmithKline Sales Growth by Geographic Region

    Table GL-12: GlaxoSmithKline Consumer Healthcare Sales by

    Product Line

    Table GL-13: GlaxoSmithKline Consumer Healthcare Sales Growth

    by Product Line

    Table JJ-1: Johnson & Johnson Sales by Geographic Region and

    Country

    Table JJ-2: Johnson & Johnson Sales Growth by Geographic

    Region

    Table JJ-3: Johnson & Johnson Sales by Business Segment and

    Geographic Region

    Table JJ-4: Johnson & Johnson Sales and Operating Profit Growth

    Table JJ-5: Johnson & Johnson Sales by Major Drug

    Table JJ-6: Johnson & Johnson Pharmaceutical Sales Growth by

    Major Drug

    Table JJ-7: Johnson & Johnson Consumer Segment Sales by

    Product Line

    Table JJ-8: Johnson & Johnson Consumer Segment Sales Growth

    by Product Line

    Table ME-1: Merck Sales and Operating Profit Growth

    Table ME-2: Merck Sales by Geographic Region

    Table ME-3: Merck Sales Growth by Geographic Region

    Table ME-4: Merck Sales by Therapeutic Category

    Table ME-5: Merck Sales Growth by Therapeutic Category

    Table ME-6: Merck Sales By Major Drug

    Table ME-7: Merck Sales Growth by Major Drug

    Table ME-8: Merck Sales By Major Drug and Geographic Region

    Table NO-1: Novartis Sales and Operating Profit Growth

    Table NO-2: Novartis Sales by Business Segment

    Table NO-3: Novartis Sales Growth by Business Segment

    Table NO-4: Novartis Operating Profit by Business Segment

    Table NO-5: Novartis Operating Profit Growth by Business

    Segment

    Table NO-6: Novartis Sales by Country

    Table NO-7: Novartis Sales Growth by Country

    Table NO-8: Novartis Sales by Therapeutic Category

    Table NO-9: Novartis Sales Growth by Therapeutic Category

    Table NO-10: Novartis Sales of Top 20 Drugs

    Table NO-11: Novartis Sales Growth by Major Drug

    Table PF-1: Pfizer Sales by Division

    Table PF-2: Pfizer Sales and Operating Profit Growth

    Table PF-3: Pfizer Sales by Therapeutic Category

    Table PF-4: Pfizer Sales by Major Product

    Table PF-5: Pfizer Sales Growth by Major Product

    Table PF-6: Pfizer Sales by Geographic Region

    Table PF-7: Pfizer Sales Growth by Geographic Region

    Table RO-1: Roche Sales and Operating Profit Growth

    Table RO-2: Roche Sales by Major Division

    Table RO-3: Roche Sales Growth by Business Segment

    Table RO-4: Roche Sales by Geographic Region

    Table RO-5: Roche Sales Growth by Geographic Region

    Table RO-6: Roche Sales and Operating Profit Growth

    Table RO-7: Roche Sales by Division

    Table RO-8: Roche Operating Profit by Division

    Table RO-9: Roche Operating Profit Growth by Division

    Table RO-10: Roche Sales by Therapeutic Category

    Table RO-11: Roche Sales of Top 20 Products

    Table SA-1: Sanofi-Aventis Sales and Operating Profit Growth

    Table SA-2: Sanofi-Aventis Sales by Business Segment

    Table SA-3: Sanofi-Aventis Sales Growth by Business Segment

    Table SA-4: Sanofi-Aventis Sales of Top 15 Drugs

    Table SA-5: Sanofi-Aventis Sales Growth of Top 15 Drugs

    Table SA-6: Sanofi-Aventis Sales of 15 Major Drugs and

    Geographic Region

    Table SA-7: Sanofi-Aventis Sales by Geographic Region

    Table SA-8: Sanofi-Aventis Vaccine Sales by Major Product

    Table WY-1: Wyeth Sales by Business Segment

    Table WY-2: Wyeth Sales Growth by Business Segment

    Table WY-3: Wyeth Sales and Operating Profit Growth

    Table WY-4: Wyeth Sales by Therapeutic Category

    Table WY-5: Wyeth Sales by Major Drug

    Table WY-6: Wyeth Consumer Healthcare Sales by Product

    Table WY-7: Wyeth Consumer Healthcare Sales Growth by

    Product

    Table CA-1: The Top 10 World's Leading Pharmaceutical

    Companies Sales, Rank, and Market Share

    Table CA-2: The Top 10 World's Leading Pharmaceutical

    Companies Operating Profit, Margins, and Rank

    Table CA-3: The Top 10 World's Leading Pharmaceutical

    Companies R&D Expenditures, Percent of Sales,

    and Rank

    To order this report:Pharmaceutical Industry: Top Ten World's Leading Pharmaceutical Companies

    Pharmaceutical Business News

    More  Market Research Report

    Check our  Company Profile, SWOT and Revenue Analysis!Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626
    '/>"/>

    SOURCE Reportlinker
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Reportlinker Adds Top Ten Worlds Leading Life Science Intermediates Companies
    2. Reportlinker Adds Global Blood Glucose Meters and Strips Industry
    3. Reportlinker Adds Global Ambulatory & Bathroom Aids Industry
    4. Reportlinker Adds Global Insulin Pumps (External) Industry
    5. Reportlinker Adds Global Antibiotics Industry
    6. Reportlinker Adds Global Medical Specialty Bags Industry
    7. Reportlinker Adds Global Ophthalmic Instrumentation Industry
    8. Reportlinker Adds Global Nuclear Medicine Industry
    9. Reportlinker Adds U.S. Inflammatory Diseases Drug Delivery: Physician Perspective
    10. Reportlinker Adds Proteomics - Technologies, Markets and Companies
    11. Reportlinker Adds Cardiovascular Surgical Devices: The Global Market
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/9/2016)... , February 9, 2016 ... a collaboration with 10x Genomics to develop and ... biology and bioinformatics. --> QGEN ; ... with 10x Genomics to develop and promote comprehensive ... bioinformatics. --> QIAGEN N.V. (NASDAQ: ...
    (Date:2/9/2016)... 9, 2016 Amarantus BioScience Holdings, ... developing products for Regenerative Medicine, Neurology and Orphan Diseases, ... company at Source Capital Group,s 2016 Disruptive Growth & ... in New York City . The ... 2016 at 12:30 pm by Gerald E. Commissiong ...
    (Date:2/9/2016)... 2016 The leader in accelerated orthodontics, OrthoAccel ... is the recipient of the 2015 Townie Choice Award ... II medical device that speeds up orthodontic tooth movement ... often associated with treatment, AcceleDent was selected by orthodontists ... Orthotown survey of the most reliable and ...
    Breaking Medicine Technology:
    (Date:2/9/2016)... ... 09, 2016 , ... Shark Finds and Kevin Harrington, and the Product Managers of ... GRIP-DRY is a newly patented product that has solved some of the basic problems golfers ... early morning dew or right after a rain shower, might understand the struggle of placing ...
    (Date:2/8/2016)... ... February 08, 2016 , ... The Federal Laboratory Consortium for ... The site houses a wealth of federal resources that businesses can leverage to ... technology transfer (T2). As a network of over 300 federal laboratories, the FLC’s ...
    (Date:2/8/2016)... , ... February 08, 2016 , ... ... in Houma, LA, celebrates the beginning of a new charity campaign. As part ... Court Appointed Special Advocates (CASA). In the belief that children deserve a voice, ...
    (Date:2/8/2016)... Alexandria, Minn. (PRWEB) , ... February 08, 2016 ... ... introduces the BantamPro L top-load case packer for pouches, bags, and flow wrapped ... designed to help co-packers and specialty product manufacturers step up to semi-automatic or ...
    (Date:2/8/2016)... ... February 08, 2016 , ... Steve Helwig & Associates Insurance & Financial, serving ... program, has teamed up with Citizens Opposed to Domestic Abuse in support of its ... support all those victimized by the fear of violence in their own homes, donations ...
    Breaking Medicine News(10 mins):